More than 4 million families have already stored the umbilical cord blood of their newborns

In recent years, more and more parents-to-be worldwide have been signing contracts with biobanks on the storage of umbilical cord blood after childbirth. Today, more than 4,000,000 umbilical cord blood biodeposits have been stored in family type banks, and nearly 1,000,000 parents gave cord blood of their newborns to state (public) biobanks. The latter provide donor cord blood to hematologic clinics for the treatment of patients, having indications to bone marrow transplant, since umbilical cord blood is officially recognized as an alternative to it.

The first umbilical cord blood hematopoietic stem cell transplant was performed in France in 1988 to a boy with Fanconi anemia. Today, Matthew Feraud, this is the name of the world’s first cord blood stem cell recipient in the world, is a healthy 36 year old man, who enjoys a full life with his family and promotes the development of umbilical cord blood banks in the world.

The first umbilical cord blood bank was established in the United States in 1992, and the founder became its first client, having stored the cord blood of his newborn son at the newly created company.

As of 2019, banks of umbilical cord blood of various forms of ownership are successfully operating in almost all countries of the world, and the number of umbilical cord blood stem cells transplants has already exceeded 40,000. It is important to note that if before, umbilical cord blood was considered as a transplant of hematopoietic stem cells mainly for children with a body weight below 40 kg, now the number of applications of this biomaterial in adults exceeds their quantity in children. This is facilitated by the worked out methods of cultivation (expansion) of umbilical cord blood stem cells, which allow to increase safely their number. Among the recipients of the umbilical cord blood are patients over the age of 60 years. The largest number of transplants of umbilical cord blood stem cells is being performed in Japan, about 5,000 transplants annually.

Ukrainian parents also have the opportunity to store their newborns’ umbilical cord blood, umbilical cord and placenta in the first and only ISO accredited Cryobank of the Institute of Cell Therapy in accordance with international standards for cryopreservation of perinatal tissues.